BlackRock’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $192M | Buy |
10,684,103
+364,934
| +4% | +$5.1M | ﹤0.01% | 1825 |
|
|
2026
Q1 | $97.2M | Sell |
10,319,169
-28,557
| -0.3% | -$314K | ﹤0.01% | 2127 |
|
|
2025
Q4 | $129M | Buy |
10,347,726
+118,543
| +1% | +$1.58M | ﹤0.01% | 1942 |
|
|
2025
Q3 | $147M | Sell |
10,229,183
-122,569
| -1% | -$1.68M | ﹤0.01% | 1851 |
|
|
2025
Q2 | $127M | Sell |
10,351,752
-387,291
| -4% | -$5.62M | ﹤0.01% | 1892 |
|
|
2025
Q1 | $236M | Sell |
10,739,043
-389,347
| -3% | -$9.16M | 0.01% | 1498 |
|
|
2024
Q4 | $252M | Buy |
11,128,390
+242,167
| +2% | +$5.29M | 0.01% | 1534 |
|
|
2024
Q3 | $198M | Sell |
10,886,223
-367,181
| -3% | -$8.51M | ﹤0.01% | 1666 |
|
|
2024
Q2 | $328M | Buy |
11,253,404
+4,605,646
| +69% | +$137M | 0.01% | 1288 |
|
|
2024
Q1 | $236M | Buy |
6,647,758
+5,913
| +0.1% | +$236K | 0.01% | 1539 |
|
|
2023
Q4 | $289M | Sell |
6,641,845
-192,342
| -3% | -$7.57M | 0.01% | 1393 |
|
|
2023
Q3 | $261M | Buy |
6,834,187
+58,738
| +0.9% | +$2.47M | 0.01% | 1365 |
|
|
2023
Q2 | $279M | Sell |
6,775,449
-237,386
| -3% | -$11.4M | 0.01% | 1346 |
|
|
2023
Q1 | $403M | Sell |
7,012,835
-130,401
| -2% | -$7.35M | 0.01% | 1057 |
|
|
2022
Q4 | $401M | Sell |
7,143,236
-45
| -0% | -$2.29K | 0.01% | 1034 |
|
|
2022
Q3 | $303M | Buy |
7,143,281
+442,760
| +7% | +$22.7M | 0.01% | 1165 |
|
|
2022
Q2 | $362M | Sell |
6,700,521
-47,135
| -0.7% | -$2.83M | 0.01% | 1094 |
|
|
2022
Q1 | $434M | Sell |
6,747,656
-11,836
| -0.2% | -$779K | 0.01% | 1087 |
|
|
2021
Q4 | $453M | Buy |
6,759,492
+111,789
| +2% | +$7.56M | 0.01% | 1102 |
|
|
2021
Q3 | $455M | Buy |
6,647,703
+28,549
| +0.4% | +$2.02M | 0.01% | 1056 |
|
|
2021
Q2 | $452M | Buy |
6,619,154
+82,154
| +1% | +$5.81M | 0.01% | 1094 |
|
|
2021
Q1 | $452M | Buy |
6,537,000
+113,989
| +2% | +$7.72M | 0.01% | 1089 |
|
|
2020
Q4 | $417M | Buy |
6,423,011
+10,249
| +0.2% | +$552K | 0.01% | 1028 |
|
|
2020
Q3 | $303M | Sell |
6,412,762
-117,043
| -2% | -$5.57M | 0.01% | 1068 |
|
|
2020
Q2 | $307M | Sell |
6,529,805
-16,543
| -0.3% | -$813K | 0.01% | 1038 |
|
|
2020
Q1 | $292M | Sell |
6,546,348
-121,678
| -2% | -$6.39M | 0.01% | 901 |
|
|
2019
Q4 | $389M | Buy |
6,668,026
+102,434
| +2% | +$6.1M | 0.01% | 994 |
|
|
2019
Q3 | $394M | Sell |
6,565,592
-87,479
| -1% | -$5.21M | 0.02% | 916 |
|
|
2019
Q2 | $372M | Sell |
6,653,071
-34,627
| -0.5% | -$1.78M | 0.02% | 974 |
|
|
2019
Q1 | $373M | Sell |
6,687,698
-42,606
| -0.6% | -$2.17M | 0.02% | 940 |
|
|
2018
Q4 | $304M | Buy |
6,730,304
+210,960
| +3% | +$11.6M | 0.02% | 999 |
|
|
2018
Q3 | $429M | Buy |
6,519,344
+107,781
| +2% | +$6.7M | 0.02% | 851 |
|
|
2018
Q2 | $413M | Sell |
6,411,563
-1,959,748
| -23% | -$121M | 0.02% | 862 |
|
|
2018
Q1 | $463M | Buy |
8,371,311
+235,759
| +3% | +$12.4M | 0.02% | 747 |
|
|
2017
Q4 | $389M | Buy |
8,135,552
+269,484
| +3% | +$13.2M | 0.02% | 861 |
|
|
2017
Q3 | $397M | Buy |
7,866,068
+469,167
| +6% | +$24.1M | 0.02% | 808 |
|
|
2017
Q2 | $403M | Sell |
7,396,901
-58,663
| -0.8% | -$2.8M | 0.02% | 770 |
|
|
2017
Q1 | $314M | Buy |
7,455,564
+7,450,720
| +153,813% | +$318M | 0.02% | 931 |
|
|
2016
Q4 | $208K | Sell |
4,844
-788
| -14% | -$32K | ﹤0.01% | 2120 |
|
|
2016
Q3 | $232K | Buy |
5,632
+454
| +9% | +$19K | ﹤0.01% | 2077 |
|
|
2016
Q2 | $207K | Buy |
5,178
+1,146
| +28% | +$41.2K | ﹤0.01% | 2079 |
|
|
2016
Q1 | $136K | Buy |
4,032
+2,332
| +137% | +$72.6K | ﹤0.01% | 1852 |
|
|
2015
Q4 | $57K | Sell |
1,700
-398
| -19% | -$12.4K | ﹤0.01% | 1977 |
|
|
2015
Q3 | $62K | Buy |
2,098
+469
| +29% | +$14.7K | ﹤0.01% | 1833 |
|
|
2015
Q2 | $45K | Sell |
1,629
-62
| -4% | -$1.65K | ﹤0.01% | 2018 |
|
|
2015
Q1 | $43K | Hold |
1,691
| – | – | ﹤0.01% | 2016 |
|
|
2014
Q4 | $37K | Hold |
1,691
| – | – | ﹤0.01% | 2093 |
|
|
2014
Q3 | $34K | Hold |
1,691
| – | – | ﹤0.01% | 2094 |
|
|
2014
Q2 | $32K | Buy |
1,691
+93
| +6% | +$1.73K | ﹤0.01% | 2136 |
|
|
2014
Q1 | $30K | Hold |
1,598
| – | – | ﹤0.01% | 2160 |
|
|
2013
Q4 | $32K | Hold |
1,598
| – | – | ﹤0.01% | 2119 |
|
|
2013
Q3 | $27K | Hold |
1,598
| – | – | ﹤0.01% | 2116 |
|
|
2013
Q2 | $24K | Buy |
+1,598
| New | +$23.4K | ﹤0.01% | 2203 |
|
Other funds holding IART
RCMNY
PCMI
BlackRock's IART Position: Q2 2026 in Review
BlackRock increased its Integra LifeSciences (IART) stake by 3.5% in Q2 2026, buying an estimated $5.1M and bringing the position to 10,684,103 shares worth $192M. The position accounts for ﹤0.01% of the portfolio, ranked #1825.
BlackRock first reported a position in IART in Q2 2013 and has held it in 53 quarters since. The position peaked at $463M in Q1 2018. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.
- BlackRock held 10,684,103 shares of Integra LifeSciences worth $192M as of Q2 2026.
- BlackRock bought 364,934 Integra LifeSciences shares in Q2 2026, an estimated $5.1M.
- Integra LifeSciences made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #1825 holding.
- BlackRock first reported a position in Integra LifeSciences in Q2 2013 and has held it in 53 quarters since.
- BlackRock's Integra LifeSciences position peaked at $463M in Q1 2018.
- 212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.
Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.